Unusual Options Activity: Traders bet Eli Lilly and Company (LLY) Stock Will Hold its Recent Gains After Hitting New All-Time High
Traders are betting Wednesday that Eli Lilly and Company (LLY) will hold its recent gains. The stock hit a new all-time high today of $130.75. So far today, 9,023 contracts of the May 125 call have changed hands, against open interest of just 79contracts.
Already a member?
Login to see your Unusual Options Activity Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Eli Lilly and Company
Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.